vimarsana.com
Home
Live Updates
DBV Technologies Announces 2-Year Results from Ongoing Phase
DBV Technologies Announces 2-Year Results from Ongoing Phase
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
Montrouge, France, November 9, 2023 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial of Viaskin™ Peanut in Toddlers Viaskin Peanut showed...
Related Keywords
United States ,
France ,
Colorado ,
Montrouge ,
France General ,
American ,
Katie Matthews ,
Matthew Greenhawt ,
Eleanor Garrow ,
Angela Marcucci ,
Matthewc Greenhawt ,
Anaphylaxis Connection Team ,
Company Adss ,
American College Of Allergy ,
Exchange Commission ,
Year Results ,
Ongoing Phase ,
Label Extension ,
American College ,
Nasdaq Stock Market ,
Open Label Extension ,
Viaskin Peanut ,
Daniel Tass ,
Chief Executive Officer ,
Annual Scientific Meeting ,
New England Journal ,
Hospital Colorado ,
Breaking Abstract ,
Peanut Allergic Toddlers ,
Anschutz Medical Campus ,
Late Breaking Oral Abstracts ,
Poster Area ,
Eleanor Garrow Holding ,
Food Allergy ,
Anaphylaxis Connection ,
Conference Call ,
North American ,
Basking Ridge ,
Euronext Paris ,
Nasdaq Global Select Market ,
Des March ,
Markets ,